Lv3
224 积分 2021-02-07 加入
Managing Metabolic Syndrome and Prostate Cancer
18小时前
求助中
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery
2天前
已完结
Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial
2天前
已完结
Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing
3天前
已关闭
Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity
3天前
已完结
Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer
3天前
已完结
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
5天前
已完结
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial
8天前
已完结
Mathematical Biomarkers of Adaptive Therapy Outcomes in Prostate Cancer
11天前
已完结
AI-based augmentation of oncology clinical trials
12天前
已完结
皖公网安备34019202002308
